Lay Summary
Association between anti-depressants drugs on the progression of multiple sclerosis.
Researchers found no evidence to suggest that exposure to the antidepressants ‘selective serotonin reuptake inhibitors’ were associated with a delay in MS disability accumulation or progression.
